Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
European Journal of Clinical Pharmacology|January 1, 1997
Debrisoquine and S-mephenytoin hydroxylation polymorphisms in a Russian population living in EstoniaT Marandi, M L Dahl, L Rägo, et al.
British Journal of Clinical Pharmacology|January 1, 1994
Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphismsM L Dahl, A Llerena, U Bondesson, et al.
The Pharmacogenomics Journal|June 7, 2002
Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytesN Finnström, B Ask, M-L Dahl, et al.
The American Journal of Psychiatry|February 1, 1995
D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoateS Nyberg, L Farde, C Halldin, et al.
Scandinavian Journal of Gastroenterology|November 26, 1998
CYP2C19 genotype and phenotype determined with omeprazole in patients with acid-related disorders with and without Helicobacter pylori infectionM Sagar, R Seensalu, G Tybring, et al.
Therapeutic Drug Monitoring|April 1, 1992
Haloperidol disposition is dependent on debrisoquine hydroxylation phenotypeA Llerena, C Alm, M L Dahl, et al.
Gastroenterology|September 13, 2000
Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphismM Sagar, G Tybring, M L Dahl, et al.
Pharmacology & Toxicology|February 1, 1991
Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patientsL Bertilsson, K Otani, M L Dahl, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1995
Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basisM L Dahl, I Johansson, L Bertilsson, et al.
Pageof 11